The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000536369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
12/03/2026
Date registered
Help: Date registered
30/04/2026
Date last updated
Help: Date last updated
16/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
30/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Patient Navigation and Peer Support to Improve Survivorship for Chinese- and Vietnamese-speaking People Affected by Cancer
Scientific title
Patient Navigation and Peer Support to Improve Survivorship for Chinese- and Vietnamese-speaking People Affected by Cancer – a Phase II Pragmatic Hybrid Effectiveness–Implementation Trial (the PEARL trial)
Additional trial identifiers [1] 316641 0
None
Universal Trial Number (UTN)
U1111-1336-3351
Trial acronym
PEARL
Related trial records

Health condition
Health condition(s) studied:
Cancer 340848 0
Condition category
Condition code
Cancer 337008 337008 0 0
Any cancer
Public Health 337009 337009 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The PEARL intervention is a non-clinical bilingual patient navigation and peer support program co-designed with cancer survivors, general practitioners, community organisations, multicultural health workers, and oncology clinicians to address language, cultural, and system-level barriers experienced by Chinese- and Vietnamese-speaking people after cancer treatment. The program strategically embeds trained bilingual Patient Navigators (PNs) and Peer Facilitators (PFs) within community and primary care settings to deliver culturally responsive survivorship support, improve coordination across care settings, and strengthen integration with general practice.

Prior to participant enrolment, PNs and PFs will complete a structured training program delivered by members of the PEARL research team and senior project staff with expertise in cancer survivorship, patient navigation, and culturally and linguistically diverse (CALD) health. Training will be delivered via a combination of face-to-face workshops and/or videoconference sessions, depending on site location and availability.
Training will comprise of three phases: Phase 1 and 3 will be delivered by PEARL staff with duration approximately 3 hours, and will occur at least three-four weeks before program commencement at each site. Phase 2 will involve self-directed completion of the free online George Washington Cancer Center's Oncology Patient Navigation Training course, which will take up to 14 hours (maximum). Core training content includes: the PEARL model and study procedures; roles and boundaries of PNs and PFs; culturally responsive communication; confidentiality and ethical conduct; documentation and data collection requirements; referral pathways; and escalation procedures. Refresher training and ad-hoc support will be provided as required throughout the study. Sites may nominate delegated staff to attend training to support local capacity building and facilitate training of additional PNs/PFs if required.

The intervention consists of the following key elements:

Initial patient navigation assessment and care planning:
A trained bilingual PN will contact participants allocated to the intervention arm and arrange an initial assessment (face-to-face where feasible, otherwise via videoconference). This 30–60-minute meeting (including caregivers if preferred) identifies individual barriers to care—such as language, health literacy, psychosocial, logistical, or system obstacles—and results in a collaboratively developed, individualised care plan. The PN documents needs, establishes goals, and outlines actions to support the participant’s transition from specialist oncology care to primary care.


Ongoing navigation and peer support:
Following the initial assessment, each participant is linked with a trained PF who shares the participant’s preferred language and cultural background. PFs provide flexible, in-language support through phone, video, in-person meetings, and home visits where needed. Support includes: assisting with appointment booking and transport; helping participants understand medical information or written materials; clarifying clinician instructions; and providing practical and emotional support. PNs and PFs also assist with referrals to community services, allied health, psychosocial support, and other survivorship-related resources. The frequency and mode of contacts are tailored to participant needs and recorded in navigation activity logs.


Culturally tailored survivorship education:
Intervention participants are invited to attend a 6-week “Supporting People with Cancer” program delivered in Chinese/Vietnamese, offering culturally relevant education on symptoms, self-care, follow-up routines, and available supports. The program involves once-weekly sessions up to two hours long, delivered by a bilingual health professional and facilitator.


Primary care integration:
A central component of PEARL is strengthening the survivorship care role of general practitioners. GPs receive an enrolment notification, an overview of PEARL services, and contact details for the PN/PF. PNs facilitate communication between oncology teams and general practice and encourage development of chronic disease care plans where appropriate.
GPs and practice nurses are offered a 15–30 minute multidisciplinary case conference with the PN, PF, and patient/carer to discuss care plans and clarify roles, following relevant Medicare requirements for case conferencing (e.g., MBS Item 735). This case conference may be offered within one week after participant enrolment. PNs may also visit general practices to support implementation and coordination of recommended follow-up care.

Mode, duration, and tailoring:
PEARL uses a hub-and-spoke delivery model across hospital, community, and primary care settings. Navigation and peer support are delivered over a 12-month period to align with annual survivorship surveillance. The intervention is tailored to cultural and linguistic needs, individual preferences, and the complexity of identified barriers, with adaptations documented using standard implementation frameworks. Adherence to the program will be assessed by the clinical trial coordinator or CPI on a fortnightly (for the first 3 months) and then monthly basis, by ensuring that the patient navigators are meeting the checklist of survivorship indicators.

Intervention code [1] 333321 0
Rehabilitation
Description of the comparator or control
Participants randomised to the control group will continue to receive usual care, defined as the standard follow-up and survivorship support routinely provided by their oncology and primary care teams. Usual care pathways vary by site but typically include scheduled oncology follow-up appointments, GP-led management of general health needs, and access to existing survivorship information and support resources (e.g., Cancer Council materials). No patient navigation, peer facilitation, structured assessment of barriers, or coordinated survivorship care planning is provided as part of usual care.
Control group
Active

Outcomes
Primary outcome [1] 344534 0
Health-related Quality of Life
Timepoint [1] 344534 0
Baseline, 6 months post-baseline, 12 months post-baseline (primary timepoint)
Secondary outcome [1] 458228 0
Effectiveness - Participant reported uncertainty and modifiable contributors to difficulty in making health related decisions. This will be assessed as a composite outcome.
Timepoint [1] 458228 0
Baseline, 12 months post-baseline
Secondary outcome [2] 458231 0
Implementation - Psychosocial effects (This will be assessed as a composite outcome.)
Timepoint [2] 458231 0
Baseline, 12 months post-baseline
Secondary outcome [3] 458238 0
Implementation - Number of Barriers to Care
Timepoint [3] 458238 0
12 months post-baseline
Secondary outcome [4] 458239 0
Implementation - Barriers Resolved
Timepoint [4] 458239 0
12 months post-baseline
Secondary outcome [5] 458240 0
Implementation - Interventions Provided to Address Barriers
Timepoint [5] 458240 0
12 months post-baseline
Secondary outcome [6] 458241 0
Implementation - Volume of navigation work over time (e.g., number of new, open, and closed cases per month, by site)
Timepoint [6] 458241 0
Throughout the 12 months of the study
Secondary outcome [7] 458242 0
Implementation - Completion of required training and demonstrated competency (initial and ongoing) for staff delivering navigation
Timepoint [7] 458242 0
Throughout the 12 months of the study
Secondary outcome [8] 458243 0
Implementation - Number of navigator/facilitator contacts with participants
Timepoint [8] 458243 0
End of project
Secondary outcome [9] 458244 0
Implementation - Adherence to follow-up care
Timepoint [9] 458244 0
12 months post-baseline
Secondary outcome [10] 458245 0
Implementation - Program Adherence
Timepoint [10] 458245 0
Fortnightly for three months, then monthly for remaining duration of program
Secondary outcome [11] 458246 0
Implementation - Number of referrals to social and supportive care resources. This will be assessed as a composite outcome.
Timepoint [11] 458246 0
12 months post-baseline
Secondary outcome [12] 458247 0
Reach - Proportion of enrolled participants who remain in the study and provide outcome data at each follow-up timepoint. This will be assessed as a composite outcome.
Timepoint [12] 458247 0
End of project
Secondary outcome [13] 458248 0
Implementation - Frequency of communication between navigation staff and the treating team
Timepoint [13] 458248 0
12 months post-baseline
Secondary outcome [14] 458249 0
Implementation - Total referrals initiated through navigation (e.g., clinical services and community-based supports)
Timepoint [14] 458249 0
12 months post-baseline
Secondary outcome [15] 458250 0
Implementation - Patient experience (Patient experience will be collected directly from participating patients,)
Timepoint [15] 458250 0
12 months post-baseline
Secondary outcome [16] 458251 0
Maintenance - Participant and provider-reported expectations of navigation/program support and the extent to which expectations are met; continued engagement with recommended care pathways approximately 6 months post-intervention (this is a composite outcome - qualitative)
Timepoint [16] 458251 0
6 months post end of intervention
Secondary outcome [17] 458252 0
Implementation - Time from Referral to First Contact
Timepoint [17] 458252 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [18] 458253 0
Implementation - Adaptations Logged (Record of any modifications to delivery or procedures - what changed, when, and why)
Timepoint [18] 458253 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [19] 458256 0
Reach - Number of patients excluded/declined and reasons why
Timepoint [19] 458256 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [20] 458257 0
reach - Percent of clinically eligible patients offered the PEARL program
Timepoint [20] 458257 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [21] 458258 0
Implementation - Number of contacts with patient
Timepoint [21] 458258 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [22] 458259 0
Implementation - Number of contacts with GP/practice nurse
Timepoint [22] 458259 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [23] 458260 0
Implementation - Duration and nature of encounters (this will be assessed as a composite outcome)
Timepoint [23] 458260 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [24] 458261 0
Navigation Operational Budget (cost-effectiveness)
Timepoint [24] 458261 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [25] 458266 0
Attendance at initial case coordinator appointment
Timepoint [25] 458266 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [26] 458294 0
Implementation - Navigator and peer facilitator turnover/attrition
Timepoint [26] 458294 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [27] 458295 0
Implementation - Patient attendance at education or support programs
Timepoint [27] 458295 0
12 months post-baselined
Secondary outcome [28] 458850 0
Implementation - Number of missed follow ups
Timepoint [28] 458850 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [29] 458951 0
Adverse events
Timepoint [29] 458951 0
End of project (after all participants have completed their 12-month program)
Secondary outcome [30] 459528 0
Implementation - Type of Barriers to Care
Timepoint [30] 459528 0
12 months post-baseline
Secondary outcome [31] 459529 0
Implementation -Mode of navigator/facilitator contacts with participants
Timepoint [31] 459529 0
End of project
Secondary outcome [32] 459530 0
Implementation - Timing of navigator/facilitator contacts with participants
Timepoint [32] 459530 0
End of project
Secondary outcome [33] 459531 0
Implementation - Type of referrals to social and supportive care resources
Timepoint [33] 459531 0
12 months post-baseline
Secondary outcome [34] 459532 0
Implementation - Number of delayed follow ups
Timepoint [34] 459532 0
End of project (after all participants have completed their 12 month program)
Secondary outcome [35] 460982 0
Implementation - Caregiver experience
Timepoint [35] 460982 0
12 months post-baseline

Eligibility
Key inclusion criteria
• Adults (18 years or older) who have completed active treatment with curative intent for any cancer (except non-melanoma skin cancer) within the past 2 years, or who are living with advanced cancer (treatable but not curable)
• Speak Chinese (Mandarin/Cantonese) or Vietnamese at home
• Agree for the research/patient navigation team to liaise with their GP and treating oncologist and to access GP/hospital records
• May be receiving long-term endocrine, immunotherapy, or targeted therapy
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Prior or current participation in a patient navigation program
• Treatment with palliative intent only, with <6 months of life expectancy judged by the treating cancer specialist (urologist/oncologist) where it can be established
• Unable or unwilling to provide informed consent
• Plans to move overseas or interstate
• At the discretion of the treating clinician, presence of severe mental, cognitive, or physical conditions that limit participation

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation by computer
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participants will be randomly allocated 1:1 to intervention or control arms, using a sequence computer-generated by the biostatistician not involved in the participant recruitment and data collection. Randomisation will use random permuted blocks of varying sizes and stratified by site and preferred language (Chinese/Vietnamese).
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Statistical analysis will be conducted Statistical Software version 17 (or later). Participant characteristics and outcomes measured at baseline (and follow-up time points as appropriate) will be summarised by each study arm using descriptive statistics.

Primary analysis will be intention-to-treat, where all participants randomised will be included in the analysis according to their allocated study arm. Difference between arms for mean HRQoL scores at 6 and 12 months will be estimated using linear mixed effects models with fixed effects for study arm, time (baseline, 6 and 12 months), site and language group, and random effects for individuals (to allow for repeated outcome measures on the same individual over time) and a two-way interaction term between study arm and time. The model adjusts for baseline HRQoL score, which will be constrained to be equal between the two study arms. Adjusted estimates of the between-arm difference for mean HRQoL scores at 6 and 12 months will be reported with their respective two-sided 95% confidence intervals and p-values. Similar regression analyses, appropriate to the type of secondary outcome da-ta will be conducted. There will be no adjustments will be made for multiplicity of testing, and no interim analysis is planned.

Qualitative data will be analysed using thematic analysis techniques. Two members of the research team will code the data independently and using an inductive-deductive approach, informed by the revised RE-AIM framework, using qualitative data analysis software, NVivo. A thematic framework of coding, data sorting and summation/synthesis of data will be referenced to assess the content of all interviews. The transcripts will be repeatedly read to gain a sense of generated codes initially while creating the thematic framework to help the researchers identify recurrent patterns. Discussions with the research team will be carried out until an agreement is reached for any coding discrepancies.

Quantitative implementation outcomes will be analysed descriptively. Metrics relating to RE-AIM (including enrolment and retention rates, referral pathways, participant engagement, navigator activity logs, barriers identified and addressed, program adherence, training completion, timeliness of contacts, and frequency and mode of encounters) will be summarised using counts, proportions, means, standard deviations, medians, and interquartile ranges as appropriate. Site-level and study arm descriptive summaries will be presented to characterise variation in implementation processes across settings.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA
Recruitment hospital [1] 29226 0
The Royal Adelaide Hospital - Adelaide
Recruitment hospital [2] 29227 0
The Queen Elizabeth Hospital - Woodville
Recruitment hospital [3] 29228 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [4] 29229 0
Logan Hospital - Meadowbrook
Recruitment hospital [5] 29230 0
Bankstown-Lidcombe Hospital - Bankstown
Recruitment hospital [6] 29231 0
Liverpool Hospital - Liverpool
Recruitment hospital [7] 29232 0
Westmead Hospital - Westmead
Recruitment postcode(s) [1] 45534 0
5000 - Adelaide
Recruitment postcode(s) [2] 45535 0
5011 - Woodville
Recruitment postcode(s) [3] 45536 0
4102 - Woolloongabba
Recruitment postcode(s) [4] 45537 0
4131 - Meadowbrook
Recruitment postcode(s) [5] 45538 0
2200 - Bankstown
Recruitment postcode(s) [6] 45539 0
2170 - Liverpool
Recruitment postcode(s) [7] 45540 0
2145 - Westmead

Funding & Sponsors
Funding source category [1] 321255 0
Government body
Name [1] 321255 0
Department of Health, Disability and Ageing - Medical Research Future Fund
Country [1] 321255 0
Australia
Primary sponsor type
University
Name
Flinders University
Address
Country
Australia
Secondary sponsor category [1] 324031 0
None
Name [1] 324031 0
Address [1] 324031 0
Country [1] 324031 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319783 0
Central Adelaide Local Health Network HREC
Ethics committee address [1] 319783 0
Ethics committee country [1] 319783 0
Australia
Date submitted for ethics approval [1] 319783 0
27/02/2026
Approval date [1] 319783 0
11/08/2026
Ethics approval number [1] 319783 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148386 0
A/Prof Carolyn Ee
Address 148386 0
Flinders University, Sturt Road, Bedford Park SA 5042 GPO Box 2100 Adelaide SA 5001
Country 148386 0
Australia
Phone 148386 0
+61 413 319 830
Fax 148386 0
Email 148386 0
Contact person for public queries
Name 148387 0
Carolyn Ee
Address 148387 0
Flinders University, Sturt Road, Bedford Park SA 5042 GPO Box 2100 Adelaide SA 5001
Country 148387 0
Australia
Phone 148387 0
+61 413 319 830
Fax 148387 0
Email 148387 0
Contact person for scientific queries
Name 148388 0
Carolyn Ee
Address 148388 0
Flinders University, Sturt Road, Bedford Park SA 5042 GPO Box 2100 Adelaide SA 5001
Country 148388 0
Australia
Phone 148388 0
+61 413 319 830
Fax 148388 0
Email 148388 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.